The U.S. Food and Drug Administration expanded approval for Johnson & Johnsons nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the com… [read more]
Blog
The U.S. Food and Drug Administration expanded approval for Johnson & Johnsons nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the com… [read more]
/cdn.vox-cdn.com/uploads/chorus_asset/file/25727434/2182725205.jpg)
